Final results of a randomized comparison of infusional 5-fluorouracil/leucovorin plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) in metastatic colorectal carcinoma (MCRC)

被引：0
|
作者：
Porschen, Rainer
Kubicka, S.
Grothey, A.
Grateven, U.
Kretzschmar, A.
Greil, R.
Freier, W.
Seufferlein, T.
Arkenau, Ht
Hinke, A.
Schmoll, Hj
Schmiegel, W.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A582 / A582
页数：1
相关论文
共 50 条
  • [21] Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials
    Hong-Bin Xu
    Fang Huang
    Rui Su
    Fu-Ming Shen
    Qian-Zhou Lv
    [J]. European Journal of Clinical Pharmacology, 2015, 71 : 589 - 601
  • [22] Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4165 - 4167
  • [23] Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer
    Chiara, S
    Nobile, MT
    Gozza, A
    Taveggia, P
    Heouaine, A
    Pastrone, I
    Percivale, PL
    Lionetto, R
    Sanguineti, O
    Rosso, R
    [J]. ANTICANCER RESEARCH, 2004, 24 (01) : 355 - 360
  • [24] Phase III trial of infusional 5-fluorouracil/folinic acid plus oxalipiatin (FUFOX) versus capecitabine plus oxalipiatin (CAPOX) as first line treatment of advanced colorectal carcinoma (ACRC): results of an interim efficacy and safety analysis
    Arkenau, Hendrik T.
    Kubicka, S.
    Grall, R.
    Seufferlein, T.
    Freier, W.
    Graeven, U.
    Grothey, A.
    Hinke, A.
    Schmoll, H.
    Porschen, R.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 72 - 72
  • [25] CAPECITABINE AND OXALIPLATIN (CAPOX) PLUS CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA WHO PROGRESSED AFTER OXALIPLATIN-BASED CHEMOTHERAPY
    Petrovic, Z.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
  • [26] Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials (vol 26, pg 5910, 2008)
    Arkenau
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5859 - 5859
  • [27] Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin
    Cui, Wei
    Fan, Wenzhe
    Zhang, Qun
    Wen, Jia
    Huang, Yonghui
    Yang, Jianyong
    Li, Jiaping
    Wang, Yu
    [J]. ONCOTARGET, 2017, 8 (45) : 79165 - 79174
  • [28] Randomized multicenter phase III trial of oxaliplatin plus raltitrexed compared to oxaliplatin plus fluorouracil and leucovorin treatment in recurrent and metastatic colorectal cancer
    Wang, J.
    Li, J.
    Qin, S.
    Liu, T.
    Ye, Z.
    Zheng, L.
    Tao, M.
    Zhuang, Z.
    Zhang, Q.
    Xu, N.
    Zhang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx): A randomized phase II trial in advanced pancreatic cancer.
    Heinemann, V
    Hoehler, T
    Seipelt, G
    Wein, A
    Golf, A
    Mahlberg, R
    Schmid, B
    Boeck, S
    Neugebauer, S
    Hochhaus, A
    Grosshadern, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 315S - 315S
  • [30] A Randomized Multicenter Trial of Capecitabine plus Oxaliplatin (CapOx) versus Capecitabine plus Gemcitabine (CapGem) versus Gemcitabine plus Oxaliplatin (GemOx) in the treatment of patients with advanced pancreatic cancer
    Golf, Alexander
    Hoehler, Thomas
    Seipelt, Gernot
    Mahlberg, Rolf
    Wein, Axel
    Hichhaus, Andreas
    Schmid, Birgit
    Boeck, Hans-Peter
    Hinke, Axel
    Boeck, Stefan
    Heinemann, Volker
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 243 - 243
12345